Next-Generation Sequencing for Minimal Residual Disease Detection in AML: Current Technologies and Clinical Implications.
Minimal residual disease (MRD) has become a significant predictor of relapse and survival in acute myeloid leukemia (AML), indicating the extent of remission beyond traditional ...